Status:
RECRUITING
Relevance of a Telemedicine Monitoring in the Management of Depression
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Major depressive disorder (MDD) is a common chronic disease. It is the main cause of morbidity and disability in the world with, among other things, an increase in cardio-metabolic risk and a reductio...
Detailed Description
Major depressive disorder (MDD) is a common and often chronic disease. It is the main cause of morbidity and disability in the world with, among other things, an increase in cardio-metabolic risk (dia...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Presence of DSM5 criteria for the diagnosis of a characterized depressive episode
- Patient hospitalized in MCO with request for liaison psychiatry opinion whatever the hospitalization modality (full hospitalization, weekday hospitalization or day hospitalization)
- Initiation, change of molecule or modification of a psychotropic treatment (antidepressant or anxiolytic) during MCO hospitalization by the liaison psychiatrist
- Affiliated or entitled to a social security system (except AME)
- Obtaining free, written and informed consent
Exclusion
- Severity of the depressive episode incompatible with outpatient care and relevant to an indication for hospitalization in psychiatry
- Patient is part of a psychiatric care program at the time of the selection visit
- Presence of a mood disorder other than CDD
- Reason for MCO hospitalization secondary to psychiatric disorders, in particular suicide attempts
- MCO hospitalization prolonged beyond 3 weeks after initiation, change of molecule or modification of psychotropic treatment dosage
- Psychiatric comorbidities assessed by psychiatrist, in particular addictions (excluding tobacco), delusional disorders, post-traumatic stress disorder, anxiety disorders (excluding GAD)
- High suicidal risk at the screening visit assessed by psychiatrist
- Presence of a non-psychiatric condition with a vital prognosis of less than 3 years
- Contraindications to telemedicine (no internet access, major vision problems, major cognitive problems, marked impulsivity, clinical situation requiring information to be communicated in person, etc.)
- Conditions making consent impossible (major cognitive disorders, etc.)
- Deprived of liberty or under a protective measure (guardianship or under curatorship)
- Pregnant woman
- Refusal of the patient
Key Trial Info
Start Date :
May 27 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 2 2029
Estimated Enrollment :
836 Patients enrolled
Trial Details
Trial ID
NCT06076317
Start Date
May 27 2024
End Date
February 2 2029
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Pitié Salpêtrière
Paris, France, 75013